Key result
Hematopoietic progenitor cell metabolic and epigenetic rewiring drives trained immunity linked to cardiometabolic disease.
Answers are grounded in this paper and cite their sources.
Review demonstrates how trained innate immunity in hematopoietic progenitor cells drives myelopoiesis, highlighting its potential role in cardiometabolic disease.
Until recently, immunologic memory was considered an exclusive characteristic of adaptive immunity. However, recent advances suggest that the innate arm of the immune system can also mount a type of nonspecific memory responses. Innate immune cells can elicit a robust response to subsequent inflammatory challenges after initial activation by certain stimuli, such as fungal-derived agents or vaccines. This type of memory, termed trained innate immunity (also named innate immune memory), is associated with epigenetic and metabolic alterations. Hematopoietic progenitor cells, which are the cells responsible for the generation of mature myeloid cells at steady-state and during inflammation, have a critical contribution to the induction of innate immune memory. Inflammation-triggered alterations in cellular metabolism, the epigenome and transcriptome of hematopoietic progenitor cells in the bone marrow promote long-lasting functional changes, resulting in increased myelopoiesis and consequent generation of trained innate immune cells. In the present brief review, we focus on the involvement of hematopoietic progenitors in the process of trained innate immunity and its possible role in cardiometabolic disease.
No takes yet. Share an insight, caveat, or question.
Mitroulis et al. (2020) conducted a review in Cardiometabolic disease. Hematopoietic progenitor cell alterations in metabolism and the epigenome drive trained innate immunity, which may contribute to cardiometabolic disease.
Synapse has enriched 10 related papers. Consider them for comparative context: